UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Control of red blood cell hydration

Author
Carlo Brugnara, MD
Section Editor
Stanley L Schrier, MD
Deputy Editor
Jennifer S Tirnauer, MD

INTRODUCTION

The volume and hemoglobin concentration of human red blood cells are determined by the red cell content of hemoglobin, ions, and water. The water, cation, and anion contents are continuously regulated by the activity and interactions of several ion transport systems, as summarized in the figure (figure 1). The importance of these systems is indicated by the various diseases occurring when red cell ion transport is impaired (table 1).

The transport systems involved in regulating the volume and composition of red cells, and which affect the cation, anion, and water content of the red cell, will be discussed here [1]. A brief discussion of the role of ion transport in the pathogenesis of sickle cell disease will also be presented.

Cation content — In human red cells (and other cells), the activity of the sodium-K-ATPase pump maintains a low sodium, high potassium milieu. The outward potassium gradient and the inward sodium gradient can be used by several passive (gradient-driven) transport systems, which are sensitive to changes in pH, volume, or membrane integrity.

Human red cells have a high content of total magnesium, but a lower content of free magnesium. Magnesium is an important regulator of several cellular functions, but little is known about the mechanisms involved in controlling the magnesium content of the human erythrocyte.

A powerful membrane Ca-ATPase is responsible for the extremely low Ca content of human erythrocytes.

                    

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Feb 11 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Gallagher PG. Disorders of red cell volume regulation. Curr Opin Hematol 2013; 20:201.
  2. Agre P, King LS, Yasui M, et al. Aquaporin water channels--from atomic structure to clinical medicine. J Physiol 2002; 542:3.
  3. Shull GE, Schwartz A, Lingrel JB. Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA. Nature 1985; 316:691.
  4. Martin-Vasallo P, Dackowski W, Emanuel JR, Levenson R. Identification of a putative isoform of the Na,K-ATPase beta subunit. Primary structure and tissue-specific expression. J Biol Chem 1989; 264:4613.
  5. Joiner CH, Lauf PK. Ouabain binding and potassium transport in young and old populations of human red cells. Membr Biochem 1978; 1:187.
  6. TOSTESON DC, HOFFMAN JF. Regulation of cell volume by active cation transport in high and low potassium sheep red cells. J Gen Physiol 1960; 44:169.
  7. Halperin JA, Brugnara C, Kopin AS, et al. Properties of the Na+-K+ pump in human red cells with increased number of pump sites. J Clin Invest 1987; 80:128.
  8. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33:192.
  9. Segall L, Scanzano R, Kaunisto MA, et al. Kinetic alterations due to a missense mutation in the Na,K-ATPase alpha2 subunit cause familial hemiplegic migraine type 2. J Biol Chem 2004; 279:43692.
  10. de Carvalho Aguiar P, Sweadner KJ, Penniston JT, et al. Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004; 43:169.
  11. Benarroch EE. Na+, K+-ATPase: functions in the nervous system and involvement in neurologic disease. Neurology 2011; 76:287.
  12. Strehler EE, James P, Fischer R, et al. Peptide sequence analysis and molecular cloning reveal two calcium pump isoforms in the human erythrocyte membrane. J Biol Chem 1990; 265:2835.
  13. Etzion Z, Tiffert T, Bookchin RM, Lew VL. Effects of deoxygenation on active and passive Ca2+ transport and on the cytoplasmic Ca2+ levels of sickle cell anemia red cells. J Clin Invest 1993; 92:2489.
  14. Lew VL, Daw N, Perdomo D, et al. Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells. Blood 2003; 102:4206.
  15. Lew VL, Daw N, Etzion Z, et al. Effects of age-dependent membrane transport changes on the homeostasis of senescent human red blood cells. Blood 2007; 110:1334.
  16. Wiley JS, Cooper RA. A furosemide-sensitive cotransport of sodium plus potassium in the human red cell. J Clin Invest 1974; 53:745.
  17. Haas M. The Na-K-Cl cotransporters. Am J Physiol 1994; 267:C869.
  18. Xu JC, Lytle C, Zhu TT, et al. Molecular cloning and functional expression of the bumetanide-sensitive Na-K-Cl cotransporter. Proc Natl Acad Sci U S A 1994; 91:2201.
  19. Gamba G, Miyanoshita A, Lombardi M, et al. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem 1994; 269:17713.
  20. Delpire E, Rauchman MI, Beier DR, et al. Molecular cloning and chromosome localization of a putative basolateral Na(+)-K(+)-2Cl- cotransporter from mouse inner medullary collecting duct (mIMCD-3) cells. J Biol Chem 1994; 269:25677.
  21. Brugnara C, Canessa M, Cusi D, Tosteson DC. Furosemide-sensitive Na and K fluxes in human red cells. Net uphill Na extrusion and equilibrium properties. J Gen Physiol 1986; 87:91.
  22. Gillen CM, Brill S, Payne JA, Forbush B 3rd. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family. J Biol Chem 1996; 271:16237.
  23. Payne JA, Stevenson TJ, Donaldson LF. Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform. J Biol Chem 1996; 271:16245.
  24. Race JE, Makhlouf FN, Logue PJ, et al. Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter. Am J Physiol 1999; 277:C1210.
  25. Mercado A, Song L, Vazquez N, et al. Functional comparison of the K+-Cl- cotransporters KCC1 and KCC4. J Biol Chem 2000; 275:30326.
  26. Hübner CA, Stein V, Hermans-Borgmeyer I, et al. Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 2001; 30:515.
  27. Boettger T, Rust MB, Maier H, et al. Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. EMBO J 2003; 22:5422.
  28. Howard HC, Mount DB, Rochefort D, et al. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet 2002; 32:384.
  29. Boettger T, Hübner CA, Maier H, et al. Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4. Nature 2002; 416:874.
  30. Lauf PK, Bauer J, Adragna NC, et al. Erythrocyte K-Cl cotransport: properties and regulation. Am J Physiol 1992; 263:C917.
  31. Brugnara C, Kopin AS, Bunn HF, Tosteson DC. Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 1985; 75:1608.
  32. Brugnara C, Bunn HF, Tosteson DC. Regulation of erythrocyte cation and water content in sickle cell anemia. Science 1986; 232:388.
  33. De Franceschi L, Ronzoni L, Cappellini MD, et al. K-CL co-transport plays an important role in normal and beta thalassemic erythropoiesis. Haematologica 2007; 92:1319.
  34. De Franceschi L, Cappellini MD, Graziadei G, et al. The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia. Haematologica 1998; 83:118.
  35. Brugnara C, Tosteson DC. Cell volume, K transport, and cell density in human erythrocytes. Am J Physiol 1987; 252:C269.
  36. Brugnara C, Tosteson DC. Inhibition of K transport by divalent cations in sickle erythrocytes. Blood 1987; 70:1810.
  37. Godart H, Ellory JC. KCl cotransport activation in human erythrocytes by high hydrostatic pressure. J Physiol 1996; 491 ( Pt 2):423.
  38. Kaji DM, Gasson C. Urea activation of K-Cl transport in human erythrocytes. Am J Physiol 1995; 268:C1018.
  39. Olivieri O, Bonollo M, Friso S, et al. Activation of K+/Cl- cotransport in human erythrocytes exposed to oxidative agents. Biochim Biophys Acta 1993; 1176:37.
  40. Joiner CH, Rettig RK, Jiang M, et al. Urea stimulation of KCl cotransport induces abnormal volume reduction in sickle reticulocytes. Blood 2007; 109:1728.
  41. Olivieri O, Vitoux D, Galacteros F, et al. Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes. Blood 1992; 79:793.
  42. Nagel RL, Krishnamoorthy R, Fattoum S, et al. The erythrocyte effects of haemoglobin O(ARAB). Br J Haematol 1999; 107:516.
  43. Romero JR, Suzuka SM, Nagel RL, Fabry ME. Expression of HbC and HbS, but not HbA, results in activation of K-Cl cotransport activity in transgenic mouse red cells. Blood 2004; 103:2384.
  44. Joiner CH. Cation transport and volume regulation in sickle red blood cells. Am J Physiol 1993; 264:C251.
  45. Franco RS, Palascak M, Thompson H, et al. Dehydration of transferrin receptor-positive sickle reticulocytes during continuous or cyclic deoxygenation: role of KCl cotransport and extracellular calcium. Blood 1996; 88:4359.
  46. McGoron AJ, Joiner CH, Palascak MB, et al. Dehydration of mature and immature sickle red blood cells during fast oxygenation/deoxygenation cycles: role of KCl cotransport and extracellular calcium. Blood 2000; 95:2164.
  47. Franco RS, Thompson H, Palascak M, Joiner CH. The formation of transferrin receptor-positive sickle reticulocytes with intermediate density is not determined by fetal hemoglobin content. Blood 1997; 90:3195.
  48. Gibson JS, Speake PF, Ellory JC. Differential oxygen sensitivity of the K+-Cl- cotransporter in normal and sickle human red blood cells. J Physiol 1998; 511 ( Pt 1):225.
  49. Culliford SJ, Ellory JC, Gibson JS, Speake PF. Effects of urea and oxygen tension on K flux in sickle cells. Pflugers Arch 1998; 435:740.
  50. Lew VL, Bookchin RM. Ion transport pathology in the mechanism of sickle cell dehydration. Physiol Rev 2005; 85:179.
  51. Brown FC, Conway AJ, Cerruti L, et al. Activation of the erythroid K-Cl cotransporter Kcc1 enhances sickle cell disease pathology in a humanized mouse model. Blood 2015; 126:2863.
  52. Rust MB, Alper SL, Rudhard Y, et al. Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice. J Clin Invest 2007; 117:1708.
  53. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1997; 100:1847.
  54. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease. Br J Haematol 2000; 108:284.
  55. Hankins JS, Wynn LW, Brugnara C, et al. Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia. Br J Haematol 2008; 140:80.
  56. Morgan K, Canessa M. Interactions of external and internal H+ and Na+ with Na+/Na+ and Na+/H+ exchange of rabbit red cells: evidence for a common pathway. J Membr Biol 1990; 118:193.
  57. De Franceschi L, Rivera A, Bize I, et al. Murine Spherocytosis: Evidence for a Functional Interaction between Protein 4.1 and Na/H Exchange and for a "Protective" Role of the Gardos Channel Against Hemolysis (abstract). Blood 2004; 104:578a.
  58. Nunomura W, Denker SP, Barber DL, et al. Characterization of cytoskeletal protein 4.1R interaction with NHE1 (Na(+)/H(+) exchanger isoform 1). Biochem J 2012; 446:427.
  59. Féray JC, Garay R. An Na+-stimulated Mg2+-transport system in human red blood cells. Biochim Biophys Acta 1986; 856:76.
  60. Rivera A, Ferreira A, Bertoni D, et al. Abnormal regulation of Mg2+ transport via Na/Mg exchanger in sickle erythrocytes. Blood 2005; 105:382.
  61. Kolisek M, Nestler A, Vormann J, Schweigel-Röntgen M. Human gene SLC41A1 encodes for the Na+/Mg²+ exchanger. Am J Physiol Cell Physiol 2012; 302:C318.
  62. Alper SL. The band 3-related anion exchanger (AE) gene family. Annu Rev Physiol 1991; 53:549.
  63. Chu H, Breite A, Ciraolo P, et al. Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties. Blood 2008; 111:932.
  64. Jarolim P, Rubin HL, Brabec V, et al. Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood 1995; 85:634.
  65. Bruce LJ, Robinson HC, Guizouarn H, et al. Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. Nat Genet 2005; 37:1258.
  66. Guizouarn H, Martial S, Gabillat N, Borgese F. Point mutations involved in red cell stomatocytosis convert the electroneutral anion exchanger 1 to a nonselective cation conductance. Blood 2007; 110:2158.
  67. Alper SL. Molecular physiology and genetics of Na+-independent SLC4 anion exchangers. J Exp Biol 2009; 212:1672.
  68. Peters LL, Shivdasani RA, Liu SC, et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 1996; 86:917.
  69. Paw BH, Davidson AJ, Zhou Y, et al. Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet 2003; 34:59.
  70. Ribeiro ML, Alloisio N, Almeida H, et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 2000; 96:1602.
  71. Cordat E. Unraveling trafficking of the kidney anion exchanger 1 in polarized MDCK epithelial cells. Biochem Cell Biol 2006; 84:949.
  72. Perrotta S, Borriello A, Scaloni A, et al. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood 2005; 106:4359.
  73. Toye AM, Williamson RC, Khanfar M, et al. Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A. Blood 2008; 111:5380.
  74. GARDOS G. The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 1958; 30:653.
  75. Brugnara C, De Franceschi L, Alper SL. Ca(2+)-activated K+ transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins. J Biol Chem 1993; 268:8760.
  76. Stocker JW, De Franceschi L, McNaughton-Smith GA, et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 2003; 101:2412.
  77. Ishii TM, Silvia C, Hirschberg B, et al. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 1997; 94:11651.
  78. Vandorpe DH, Shmukler BE, Jiang L, et al. cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem 1998; 273:21542.
  79. Hoffman JF, Joiner W, Nehrke K, et al. The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red blood cells. Proc Natl Acad Sci U S A 2003; 100:7366.
  80. De Franceschi L, Rivera A, Fleming MD, et al. Evidence for a protective role of the Gardos channel against hemolysis in murine spherocytosis. Blood 2005; 106:1454.
  81. Bookchin RM, Ortiz OE, Lew VL. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J Clin Invest 1991; 87:113.
  82. Lew VL, Ortiz OE, Bookchin RM. Stochastic nature and red cell population distribution of the sickling-induced Ca2+ permeability. J Clin Invest 1997; 99:2727.
  83. Lew VL, Etzion Z, Bookchin RM. Dehydration response of sickle cells to sickling-induced Ca(++) permeabilization. Blood 2002; 99:2578.
  84. De Franceschi L, Saadane N, Trudel M, et al. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest 1994; 93:1670.
  85. Brugnara C, Gee B, Armsby CC, et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1996; 97:1227.
  86. Ataga KI, Smith WR, De Castro LM, et al. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood 2008; 111:3991.
  87. Romero JR, Suzuka SM, Nagel RL, Fabry ME. Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity. Blood 2002; 99:1103.
  88. Rivera A, Rotter MA, Brugnara C. Endothelins activate Ca(2+)-gated K(+) channels via endothelin B receptors in CD-1 mouse erythrocytes. Am J Physiol 1999; 277:C746.
  89. Rivera A, Jarolim P, Brugnara C. Modulation of Gardos channel activity by cytokines in sickle erythrocytes. Blood 2002; 99:357.
  90. Rapetti-Mauss R, Lacoste C, Picard V, et al. A mutation in the Gardos channel is associated with hereditary xerocytosis. Blood 2015; 126:1273.
  91. Glogowska E, Lezon-Geyda K, Maksimova Y, et al. Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis. Blood 2015; 126:1281.
  92. Andolfo I, Russo R, Manna F, et al. Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis). Am J Hematol 2015; 90:921.
  93. Halperin JA, Brugnara C, Tosteson MT, et al. Voltage-activated cation transport in human erythrocytes. Am J Physiol 1989; 257:C986.
  94. Halperin JA, Cornelius F. A voltage-activated cation transport pathway associated with the sodium pump. Biochim Biophys Acta 1991; 1070:497.
  95. Preston GM, Carroll TP, Guggino WB, Agre P. Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science 1992; 256:385.
  96. Smith BL, Preston GM, Spring FA, et al. Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest 1994; 94:1043.
  97. Preston GM, Smith BL, Zeidel ML, et al. Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science 1994; 265:1585.
  98. King LS, Choi M, Fernandez PC, et al. Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med 2001; 345:175.
  99. Faucherre A, Kissa K, Nargeot J, et al. Piezo1 plays a role in erythrocyte volume homeostasis. Haematologica 2014; 99:70.
  100. Zarychanski R, Schulz VP, Houston BL, et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood 2012; 120:1908.
  101. Andolfo I, Alper SL, De Franceschi L, et al. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood 2013; 121:3925.
  102. Vandorpe DH, Xu C, Shmukler BE, et al. Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes. PLoS One 2010; 5:e8732.
  103. Bookchin RM, Etzion Z, Sorette M, et al. Identification and characterization of a newly recognized population of high-Na+, low-K+, low-density sickle and normal red cells. Proc Natl Acad Sci U S A 2000; 97:8045.
  104. Holtzclaw JD, Jiang M, Yasin Z, et al. Rehydration of high-density sickle erythrocytes in vitro. Blood 2002; 100:3017.